JP Stock MarketDetailed Quotes

4570 Immuno-Biological Laboratories

Watchlist

522
+7+1.36%

20min DelayMarket Closed Jul 12 15:00 JST

4.86BMarket Cap26.03P/E (Static)

Immuno-Biological Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(FY)Mar 31, 2022

(FY)Mar 31, 2021

Total revenue

2.78%816.7M

11.92%268.3M

-30.13%182.89M

188.33M

177.19M

22.71%794.62M

239.71M

261.74M

7.44%647.58M

4.52%602.75M

Cost of revenue

11.76%299.41M

0.55%77.54M

1.12%71.62M

75.86M

74.39M

-1.10%267.91M

77.11M

70.83M

5.86%270.88M

-28.79%255.89M

Gross profit

-1.79%517.29M

17.32%190.76M

-41.72%111.27M

112.47M

102.8M

39.82%526.71M

162.6M

190.92M

8.60%376.7M

59.59%346.86M

Operating expense

-12.05%412.99M

-21.81%97.22M

-1.99%115.13M

98.42M

102.22M

-5.88%469.56M

124.33M

117.47M

-15.13%498.91M

-27.67%587.83M

Staff costs

0.28%177.85M

----

-10.25%177.36M

----

-0.42%197.63M

-7.91%198.46M

Selling and administrative expenses

-15.13%7.42M

----

83.66%8.75M

----

-46.25%4.76M

-94.33%8.86M

-General and administrative expense

-15.13%7.42M

----

83.66%8.75M

----

-46.25%4.76M

-94.33%8.86M

Research and development costs

-27.85%129.98M

----

-4.47%180.15M

----

-29.40%188.59M

-16.10%267.11M

Depreciation and amortization

--1.97M

----

--0

----

-Depreciation

--1.97M

----

--0

----

Other operating expenses

-7.30%95.76M

----

-4.30%103.3M

----

-4.82%107.94M

-7.58%113.41M

Operating profit

82.49%104.3M

144.45%93.54M

-105.26%-3.87M

14.05M

577K

146.77%57.15M

38.27M

73.45M

49.28%-122.22M

59.52%-240.98M

Net non-operating interest income (expenses)

-466.43%-1.04M

-326.53%-222K

-461.54%-329K

-237K

-249K

283.77%283K

98K

91K

74.25%-154K

84.30%-598K

Non-operating interest income

-93.14%93K

-78.08%80K

-109.42%-34K

--30K

--17K

178.44%1.36M

--365K

--361K

222.52%487K

75.58%151K

Non-operating interest expense

5.31%1.13M

13.11%302K

9.26%295K

--267K

--266K

67.39%1.07M

--267K

--270K

-14.42%641K

-19.64%749K

Net investment income

90.88%8.7M

200.50%3.59M

42.75%-3.19M

2.36M

5.94M

51.71%4.56M

1.2M

-5.57M

-38.03%3.01M

526.47%4.85M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

99.91%-166K

-166K

-176.1M

-175M

Income from associates and other participating interests

-33.46%-203.84M

-107.29M

-6.2M

-67.94%-152.73M

-1.16%-90.94M

Special income (charges)

-85.29%6.34M

252.17%162K

6.18M

162.71%43.12M

39.1M

46K

1,496.60%16.41M

-94.41%1.03M

Less:Other special charges

99.51%-249K

--0

-252.17%-162K

--0

---87K

-115.82%-50.62M

---45.8M

---46K

-1,946.60%-23.45M

93.85%-1.15M

Less:Write off

-181.26%-6.1M

--0

---6.1M

6.53%7.5M

--6.7M

--0

5,866.95%7.04M

-50.21%118K

Other non-operating income (expenses)

212.61%6.5M

136.46%2.71M

995.39%2.38M

946K

467K

-204.11%-5.77M

-7.44M

217K

-65.38%5.55M

22.17%16.02M

Income before tax

144.42%124.64M

147.20%99.62M

-107.82%-4.85M

17.12M

12.75M

-12.18%-280.61M

-211.06M

62.03M

19.47%-250.14M

52.84%-310.63M

Income tax

-780.45%-62.05M

-3,067.90%-66.48M

-37.90%1.42M

1.43M

1.58M

5.73%9.12M

2.24M

2.29M

5.22%8.63M

-13.10%8.2M

Net income

164.44%186.69M

177.87%166.11M

-110.50%-6.27M

15.7M

11.17M

-11.97%-289.73M

-213.3M

59.74M

18.84%-258.77M

52.28%-318.83M

Net income continuous operations

164.44%186.69M

177.87%166.11M

-110.50%-6.27M

--15.7M

--11.17M

-11.97%-289.73M

---213.3M

--59.74M

18.84%-258.77M

52.28%-318.83M

Noncontrolling interests

Net income attributable to the company

164.44%186.69M

177.87%166.11M

-110.50%-6.27M

15.7M

11.17M

-11.97%-289.73M

-213.3M

59.74M

18.84%-258.77M

52.28%-318.83M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

164.44%186.69M

177.87%166.11M

-110.50%-6.27M

15.7M

11.17M

-11.97%-289.73M

-213.3M

59.74M

18.84%-258.77M

52.28%-318.83M

Gross dividend payment

Basic earnings per share

164.47%20.05

177.90%17.84

-110.44%-0.67

1.69

1.19

-11.95%-31.1

-22.9

6.42

18.84%-27.78

54.96%-34.23

Diluted earnings per share

164.47%20.05

177.87%17.8351

-110.50%-0.6735

1.6853

1.19

-11.95%-31.1

-22.9024

6.4142

18.84%-27.78

54.96%-34.23

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(FY)Mar 31, 2022	(FY)Mar 31, 2021
Total revenue	2.78%816.7M	11.92%268.3M	-30.13%182.89M	188.33M	177.19M	22.71%794.62M	239.71M	261.74M	7.44%647.58M	4.52%602.75M
Cost of revenue	11.76%299.41M	0.55%77.54M	1.12%71.62M	75.86M	74.39M	-1.10%267.91M	77.11M	70.83M	5.86%270.88M	-28.79%255.89M
Gross profit	-1.79%517.29M	17.32%190.76M	-41.72%111.27M	112.47M	102.8M	39.82%526.71M	162.6M	190.92M	8.60%376.7M	59.59%346.86M
Operating expense	-12.05%412.99M	-21.81%97.22M	-1.99%115.13M	98.42M	102.22M	-5.88%469.56M	124.33M	117.47M	-15.13%498.91M	-27.67%587.83M
Staff costs	0.28%177.85M	----	----	----	----	-10.25%177.36M	----	----	-0.42%197.63M	-7.91%198.46M
Selling and administrative expenses	-15.13%7.42M	----	----	----	----	83.66%8.75M	----	----	-46.25%4.76M	-94.33%8.86M
-General and administrative expense	-15.13%7.42M	----	----	----	----	83.66%8.75M	----	----	-46.25%4.76M	-94.33%8.86M
Research and development costs	-27.85%129.98M	----	----	----	----	-4.47%180.15M	----	----	-29.40%188.59M	-16.10%267.11M
Depreciation and amortization	--1.97M	----	----	----	----	--0	----	----	----	----
-Depreciation	--1.97M	----	----	----	----	--0	----	----	----	----
Other operating expenses	-7.30%95.76M	----	----	----	----	-4.30%103.3M	----	----	-4.82%107.94M	-7.58%113.41M
Operating profit	82.49%104.3M	144.45%93.54M	-105.26%-3.87M	14.05M	577K	146.77%57.15M	38.27M	73.45M	49.28%-122.22M	59.52%-240.98M
Net non-operating interest income (expenses)	-466.43%-1.04M	-326.53%-222K	-461.54%-329K	-237K	-249K	283.77%283K	98K	91K	74.25%-154K	84.30%-598K
Non-operating interest income	-93.14%93K	-78.08%80K	-109.42%-34K	--30K	--17K	178.44%1.36M	--365K	--361K	222.52%487K	75.58%151K
Non-operating interest expense	5.31%1.13M	13.11%302K	9.26%295K	--267K	--266K	67.39%1.07M	--267K	--270K	-14.42%641K	-19.64%749K
Net investment income	90.88%8.7M	200.50%3.59M	42.75%-3.19M	2.36M	5.94M	51.71%4.56M	1.2M	-5.57M	-38.03%3.01M	526.47%4.85M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	99.91%-166K	0	0	0	-166K	-176.1M	-175M	0	0
Income from associates and other participating interests	0	0	0	0	0	-33.46%-203.84M	-107.29M	-6.2M	-67.94%-152.73M	-1.16%-90.94M
Special income (charges)	-85.29%6.34M	0	252.17%162K	0	6.18M	162.71%43.12M	39.1M	46K	1,496.60%16.41M	-94.41%1.03M
Less:Other special charges	99.51%-249K	--0	-252.17%-162K	--0	---87K	-115.82%-50.62M	---45.8M	---46K	-1,946.60%-23.45M	93.85%-1.15M
Less:Write off	-181.26%-6.1M	--0	--0	--0	---6.1M	6.53%7.5M	--6.7M	--0	5,866.95%7.04M	-50.21%118K
Other non-operating income (expenses)	212.61%6.5M	136.46%2.71M	995.39%2.38M	946K	467K	-204.11%-5.77M	-7.44M	217K	-65.38%5.55M	22.17%16.02M
Income before tax	144.42%124.64M	147.20%99.62M	-107.82%-4.85M	17.12M	12.75M	-12.18%-280.61M	-211.06M	62.03M	19.47%-250.14M	52.84%-310.63M
Income tax	-780.45%-62.05M	-3,067.90%-66.48M	-37.90%1.42M	1.43M	1.58M	5.73%9.12M	2.24M	2.29M	5.22%8.63M	-13.10%8.2M
Net income	164.44%186.69M	177.87%166.11M	-110.50%-6.27M	15.7M	11.17M	-11.97%-289.73M	-213.3M	59.74M	18.84%-258.77M	52.28%-318.83M
Net income continuous operations	164.44%186.69M	177.87%166.11M	-110.50%-6.27M	--15.7M	--11.17M	-11.97%-289.73M	---213.3M	--59.74M	18.84%-258.77M	52.28%-318.83M
Noncontrolling interests
Net income attributable to the company	164.44%186.69M	177.87%166.11M	-110.50%-6.27M	15.7M	11.17M	-11.97%-289.73M	-213.3M	59.74M	18.84%-258.77M	52.28%-318.83M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	164.44%186.69M	177.87%166.11M	-110.50%-6.27M	15.7M	11.17M	-11.97%-289.73M	-213.3M	59.74M	18.84%-258.77M	52.28%-318.83M
Gross dividend payment
Basic earnings per share	164.47%20.05	177.90%17.84	-110.44%-0.67	1.69	1.19	-11.95%-31.1	-22.9	6.42	18.84%-27.78	54.96%-34.23
Diluted earnings per share	164.47%20.05	177.87%17.8351	-110.50%-0.6735	1.6853	1.19	-11.95%-31.1	-22.9024	6.4142	18.84%-27.78	54.96%-34.23
Dividend per share	0	0	0	0	0	0	0	0	0	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall